| Abbe Center For Cmh | |
|
819 12th St Ste A Belle Plaine IA 52208-1708 | |
| (319) 398-3562 | |
| (319) 398-3501 |
| Full Name | Abbe Center For Cmh |
|---|---|
| Speciality | Clinic/center - Mental Health (including Community Mental Health Center) |
| Location | 819 12th St Ste A, Belle Plaine, Iowa |
| Authorized Official Name and Position | Cindy Kaestner (DIRECTOR) |
| Authorized Official Contact | 3193983562 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Abbe Center For Cmh 520 11th St Nw Cedar Rapids IA 52405-3811 Ph: (319) 398-3562 | Abbe Center For Cmh 819 12th St Ste A Belle Plaine IA 52208-1708 Ph: (319) 398-3562 |
| NPI Number | 1235305319 |
|---|---|
| Provider Enumeration Date | 05/07/2008 |
| Last Update Date | 05/07/2008 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235305319 | NPI | - | NPPES |
| 0074575 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
News Archive
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from the second of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. The clinical trial will continue to its planned 12-month endpoints.
Fate Therapeutics, Inc. received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application Number 10/997,146 entitled "Methods for Reprogramming Somatic Cells." Upon issuance, the patent will cover foundational induced pluripotent stem cell (iPSC) technology for identifying agents that enable the reprogramming of human somatic cells, including pluripotency genes, small molecules and biologics.
Capillary pCO2 can be used to distinguish idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction, research indicates.
A technique called size-fractionation performed on a sample of the mother's blood allows researchers to identify fetal DNA molecules separate from maternal DNA as a way to determine which pregnancies may be at risk for genetic disorders, according to a preliminary communication in the February 16 issue of JAMA, a theme issue on medical applications of biotechnology.
A new University of Maryland-led study finds that 'sex' between the virus responsible for the 2009 flu pandemic (H1N1) and a common type of avian flu virus (H9N2) can produce offspring - new combined flu viruses - with the potential for creating a new influenza pandemic.
› Verified 9 days ago